ÖZBEY, G. Et Al. 2014. ABCB1 C3435T polymorphism is associated with susceptibility to major depression, but not with a clinical response to citalopram in a Turkish population. PHARMACOLOGICAL REPORTS , vol.66, no.2 , 235-238.

ÖZBEY, G., Yucel, B., Taycan, S. E., Kan, D., Bodur, N. E., Arslan, T., ... PERÇİN, F. E.(2014). ABCB1 C3435T polymorphism is associated with susceptibility to major depression, but not with a clinical response to citalopram in a Turkish population. PHARMACOLOGICAL REPORTS , vol.66, no.2, 235-238.

ÖZBEY, GÜL Et Al. "ABCB1 C3435T polymorphism is associated with susceptibility to major depression, but not with a clinical response to citalopram in a Turkish population," PHARMACOLOGICAL REPORTS , vol.66, no.2, 235-238, 2014

ÖZBEY, GÜL Et Al. "ABCB1 C3435T polymorphism is associated with susceptibility to major depression, but not with a clinical response to citalopram in a Turkish population." PHARMACOLOGICAL REPORTS , vol.66, no.2, pp.235-238, 2014

ÖZBEY, G. Et Al. (2014) . "ABCB1 C3435T polymorphism is associated with susceptibility to major depression, but not with a clinical response to citalopram in a Turkish population." PHARMACOLOGICAL REPORTS , vol.66, no.2, pp.235-238.

@article{article, author={GÜL ÖZBEY Et Al. }, title={ABCB1 C3435T polymorphism is associated with susceptibility to major depression, but not with a clinical response to citalopram in a Turkish population}, journal={PHARMACOLOGICAL REPORTS}, year=2014, pages={235-238} }